SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
REGENERON PHARMACEUTICALS
(NQNM:REGN Last Sale: 541.82 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (REGN : $541.82)
$59,965,013 million Market Cap at Market Close, July 1, 2022
Employs 730.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

777 Old Saw Mill River Road Research Report Earnings Snapshot - Last 11/04/18
Tarrytown, NY 10591 Fact Sheet
Phone: (914) 347-7000 Financial Statements
Fax: (914) 347-2847 Peer Comparison
Annual Reports

P. Roy Vagelos, Chmn., Leonard S. Schleifer, Pres./CEO, Murray A. Goldberg, CFO
Engaged in research & development programs to create protein-based and small-molecule drugs to treat conditions including cancer, retinitis pigmentosa, and Lou Gehrig's disease.
Historical Charts    Technical Analysis
No Historical Data available for REGN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common REGN $541.82 $541.82 0 .0 $527.62 $544.2 874,948 $527.62 $544.2 110,673,311
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock #############

A1206
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex